Stem Cell Research and News: New York
<-- Back To RegionsStudy Showing Bone Marrow Stem Cell Therapy Fails To Repair Heart Damage
Contradicting several of the articles we have dug up here ... researchers in Germany in a new study seem to indicate no measurable benefit to stem cell derived from bone marrow injections don't appear to provide significant benefit. Now I...
Posted in Today's Stem Cell Research on March 2, 2006 01:00 AM
Stem Cells Root Cause Of All Cancers?
Well, if there was ever a reason to write that article on what the advantage of stem cell research is .. here is a classic example. Researcher Robert Weinberg, a cancer geneticist at the Whitehead Institute in Cambridge, Massachusetts is...
Posted in Today's Stem Cell Research on February 21, 2006 03:35 PM
Stem Cell Therapy For Heart Disease News
Forbes is covering reports by participants at major conference in New York on stem-cell therapy who agree that such a cure for heart disease is proving elusive. Though some studies are showing a modest benefit from these cell-transplant therapies for...
Posted in Today's Stem Cell Research on February 3, 2006 07:12 PM
CRYO-CELL Announces ISO 9001:2000 Certification
OLDSMAR, Fla., Nov. 28 - CRYO-CELL International, Inc. (OTCBB: CCEL) ("CRYO-CELL" or the "Company"), the world`s largest U-Cord(R) stem cell bank, announced today that it has achieved ISO 9001:2000 certification from BSI Americas, Inc., a leading quality management systems registrar....
Posted in Today's Stem Cell Research on December 4, 2005 09:57 PM
GE Healthcare and ThermoGenesis Announce Worldwide Distribution Agreement and R&D Collaboration
CHALFONT ST. GILES, England and RANCHO CORDOVA, Calif., Oct. 14 - GE Healthcare, a unit of General Electric Company (NYSE: GE), and ThermoGenesis (Nasdaq: KOOL) announced today a global distribution agreement and R&D partnership. The companies will jointly present the...
Posted in Today's Stem Cell Research on November 3, 2005 02:26 PM
Viacell to Present at UBS Healthcare Conference
Cambridge, MA, September 21, 2005 ― ViaCell, Inc. (Nasdaq: VIAC) today announced that the company will present at the UBS Global Life Sciences Conference taking place September 26 - 29, 2005 at the Grand Hyatt New York in New York...
Posted in Today's Stem Cell Research on September 27, 2005 05:59 PM
ThermoGenesis to Present at the UBS Global Life Science Conference
RANCHO CORDOVA, Calif., Sept. 22 - ThermoGenesis Corp. (Nasdaq: KOOL) announced today that Philip Coelho, Chairman and Chief Executive Officer, will participate in the UBS Global Life Science Conference on Wednesday, September 28, 2005 at 3:00 pm EDT. Mr. Coelho...
Posted in Today's Stem Cell Research on September 27, 2005 05:46 PM
Geron Corporation Announces Exercise Of Over-Allotment Option
Menlo Park, CA – September 20, 2005 – Geron Corporation (Nasdaq: GERN) today announced that on Monday, September 19, 2005, the underwriters of its public offering of six million shares of common stock have exercised their over-allotment option in full...
Posted in Today's Stem Cell Research on September 22, 2005 06:08 PM
Geron Corporation Announces The Pricing Of Its Common Stock Offering
Menlo Park, CA – September 16, 2005 – Geron Corporation (Nasdaq: GERN) today reported that its previously announced underwritten public offering of six million shares of common stock was priced at $9.00 per share. The gross public offering price from...
Posted in Today's Stem Cell Research on September 22, 2005 05:31 PM
Geron Corporation Announces Common Stock Offering
MENLO PARK, Calif.- Sept. 12, 2005 - Geron Corporation (Nasdaq:GERN) today announced its plans to offer six million shares of its common stock in an underwritten offering made from effective shelf registration statements. Concurrent with the underwritten offering, Merck &...
Posted in Today's Stem Cell Research on September 22, 2005 04:25 PM
National Sickle Cell Awareness Month
New York Blood Center, Kings County HospitalCenter, Civic Leaders Call on Brooklyn Community to Donate Blood In recognition of National Sickle Cell Awareness Month (September), Kathleen Grima, MD, Acting Chief Medical Officer, New York Blood Center (NYBC) and Jean G....
Posted in Today's Stem Cell Research on September 19, 2005 05:41 PM
PharmaFrontiers to Present at ValueRich Small Cap Financial Exposition
PharmaFrontiers Corp. (OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, will make a presentation at the ValueRich Small-Cap Financial Expo 2005 which will be held at the Jacob K. Javits Convention Center on September 14 and...
Posted in Today's Stem Cell Research on September 13, 2005 05:27 PM
StemCells Appoints Rodney K.B. Young CFO and VP, Finance
PALO ALTO, Calif., (September 7, 2005) – StemCells, Inc. (NASDAQ: STEM) today announced the appointment of Rodney K.B. Young as Chief Financial Officer and Vice President, Finance, effective September 6, 2005. Young brings financial and administrative experience in the healthcare...
Posted in Today's Stem Cell Research on September 9, 2005 07:02 PM
Family Cord Blood Services Assumes Leadership Role amongst Private Cord Blood Banks by Creating Choice for Clients to Make Cord Blood Stem Cells Available to the Public
Pioneer in Private Family Cord Blood Banking Leads Way to Help Grow Access to a Greater Public Pool of Cord Blood Stem Cells via "Public Donation" Option Family Cord Blood Services, a leading umbilical cord blood bank and subsidiary of...
Posted in Today's Stem Cell Research on September 2, 2005 03:43 PM
Internationally recognized stem cell researcher joins Chemokine's Scientific and Clinical Advisory Boards
VANCOUVER, Aug. 24 /PRNewswire-FirstCall/ - Chemokine Therapeutics Corp. (the Company) (OTCBB: CHKT - News; TSX: CTI - News), a biotechnology company developing peptide-based therapies to treat cancer, blood disorders, cardiovascular, and infectious diseases, today announced that Dr. Shahin Rafii, a...
Posted in Today's Stem Cell Research on August 25, 2005 02:17 PM
Followup On Stem Cell Hearth Therapy
On August 2, 2005 John McKenzie of ABC "World News Tonight” highlighted the work of Dr. Amit Patel who has demonstrated in clinical trials that patients with severe congestive heart failure who had exhausted all other treatment options showed markedly...
Posted in Today's Stem Cell Research on August 25, 2005 01:58 PM
Pall Systems Play Key Role in Landmark NIH Study on Cord Blood
East Hills, NY (August 17, 2005) - As cord blood increasingly takes front and center stage as a critical source of stem cells for transplants, it has driven the need for consistent quality standards to ensure the safety and efficacy...
Posted in Today's Stem Cell Research on August 18, 2005 06:13 PM
Cord Blood America Names Medical Advisory Board
Leaders from Broad Range of Blood and Stem Cell Disciplines to Advise Company LOS ANGELES, Aug. 17, 2005 - Cord Blood America, Inc. (OTCBB:CBAI), an umbilical cord blood stem cell preservation company, is pleased to announce the formation of an...
Posted in Today's Stem Cell Research on August 17, 2005 04:54 PM
Institute for the Study of Aging Sponsors Neurogenesis Catalyst Conference
NEW YORK, NY -- (MARKET WIRE) -- 08/16/2005 -- The Institute for the Study of Aging (ISOA), Ltd., a biomedical venture philanthropy founded by the Lauder family, is sponsoring a one-day catalyst conference entitled Neurogenesis as a Therapeutic Strategy for...
Posted in Today's Stem Cell Research on August 16, 2005 02:52 PM
Genentech In The Top At The 2005 Pharma Achievement Awards
Harvard’s Judah Folkman Honored with 2005 Lifetime Achievement Award On Monday evening, the 2005 Pharmaceutical Achievement Awards were presented in a black tie dinner ceremony at Boston’s State Room. Over 350 guests were in attendance to honor eighteen recipients of...
Posted in Today's Stem Cell Research on August 11, 2005 05:25 PM
NIGMS Funds New Stem Cell Centers
Focus on Basic Biology, Training Scientists Human embryonic stem cells have properties that make them uniquely valuable for studying virtually any cellular process. Despite their promise for research and therapeutic purposes, stem cells are difficult to grow in the laboratory...
Posted in Today's Stem Cell Research on August 11, 2005 05:10 PM
Your Average Age is 10 .. No Matter What Your ID Says
Count on family to find that one article that really makes you sit up and go "wow!". Thanks Mom ;) The New York Times is covering work by Jonas Frisen at the Karolinska Institute in Stockholm, Sweden. Essentially what he...
Posted in Today's Stem Cell Research on August 3, 2005 06:03 PM
Chemicon to Expand Labs In Temecula, California
Chemicon International company officials said this week that it will expand its work force in Southwest County, California and start producing research equipment for human embryonic stem cells. The development there is separate from its operations in Temecula, but both...
Posted in Today's Stem Cell Research on July 28, 2005 10:44 PM
NYT Talks About Stem Cell Research Assisting In Fertility
The New York Times is running an article, discussing research showing that there may be a hidden source of stem cells in the bone marrow. This cache so to speak is capabable of replenishing the ovaries with new eggs. This...
Posted in Today's Stem Cell Research on July 28, 2005 11:23 AM
Researchers Find Circulating Stem Cells Play Role in Lung Repair
HOUSTON, TEXAS — (July 27, 2005)— Circulating stem cells play a minor role in repairing lung damage, according to a team of scientists who used male and female chromosomal differences to analyze the repair process in lung transplant patients. Reporting...
Posted in Today's Stem Cell Research on July 28, 2005 10:09 AM
PhereSys Therapeutics Announces Consulting Agreement with Advanced Cell & Gene Therapy, LLC
PhereSys(TM) Therapeutics Corporation ("PhereSys") announced today that it has entered into a comprehensive consulting services agreement with Advanced Cell & Gene Therapy LLC ("ACGT"), Scott R. Burger, MD, Principal. Advanced Cell & Gene Therapy, LLC, located in Chapel Hill, North...
Posted in Today's Stem Cell Research on July 27, 2005 05:53 PM
Geron Announces Initiation of Clinical Trial for Its Telomerase Inhibitor Drug GRN163L in Patients with Chronic Lymphocytic Leukemia
MENLO PARK, Calif.--(BUSINESS WIRE)--July 27, 2005--Geron Corporation (Nasdaq:GERN) announced today that it has initiated clinical testing of its lead anti-cancer compound, GRN163L, in patients with chronic lymphocytic leukemia (CLL) at two clinical sites in the New York metropolitan area. This...
Posted in Today's Stem Cell Research on July 27, 2005 05:21 PM
Even More News out of Temple Regarding Heart Therapy and Stem Cell Research
If you've ever used a loofah in the shower, you've stirred up some stem cells. As the outer layer of skin sloughs off, stem cells in the dermis rush to repair and replace those buffed away. Now imagine a tiny...
Posted in Today's Stem Cell Research on July 22, 2005 04:59 PM
The Debate Over Testing Human Brain Cells in Primates
As many of us have likely noticed, there has been a lot of press lately about the debate over testing human brain cells within primates. What is at issue is that if stem cells are to ever show promise in...
Posted in Today's Stem Cell Research on July 15, 2005 01:54 PM
ThermoGenesis Rejoins the Russell 3000(R) Index and Becomes a Member of the Russell Microcap(TM) Index
RANCHO CORDOVA, Calif., July 5 - THERMOGENESIS CORP. (Nasdaq: KOOL) announced today that it has maintained its membership in the Russell 3000 Index and has been included in the newly-established Russell Microcap Index. Russell indexes are widely used by investment...
Posted in Today's Stem Cell Research on July 12, 2005 11:46 AM
Thermogenesis Corp. Completes Enrollment Of 150-Patient Human Clinical Trial Of CRYOSEAL® Fibrin Sealant System
RANCHO CORDOVA, California (June 22, 2005) – ThermoGenesis Corp. (NASDAQ: KOOL) announced today that enrollment is now complete for its pivotal U.S. 150-patient blinded, randomized, multi-center clinical trial for the CryoSeal Fibrin Sealant (FS) System. This pivotal trial evaluated the...
Posted in Today's Stem Cell Research on July 12, 2005 11:33 AM
Majority of Americans Back Embryonic Stem Cell Research
Overwhelming Support for U.S. Global Leadership in Research Washington, DC—Six in 10 Americans (58%) say they support using embryonic stem cells in medical research, according to a new national poll by Research!America and PARADE magazine. Three in 10 (29%) are...
Posted in Today's Stem Cell Research on July 11, 2005 08:09 PM
StemCells, Inc. Added to Russell 3000 Index
PALO ALTO, Calif. ( June 29, 2005) – StemCells, Inc. (NASDAQ: STEM) today announced its inclusion in the Russell 3000® Index. The Russell 3000® Index measures the performance of the 3,000 largest U.S. companies based on total market capitalization. Russell...
Posted in Today's Stem Cell Research on June 29, 2005 09:35 PM
A Step Forward in Stem Cell Research
NEW YORK, June 27, 2005 - According to research published today, investigators from Memorial Sloan-Kettering Cancer Center (MSKCC) have used new techniques in the laboratory that allowed them for the first time to derive unlimited numbers of purified mesenchymal precursor...
Posted in Today's Stem Cell Research on June 29, 2005 03:36 PM
Somatic Cell Nuclear Transfer Gives Old Animals Youthful Immune Cells
WORCESTER, Mass., June 29 -- Advanced Cell Technology, Inc. (OTC BB: ACTC), and its collaborators reported today the long-term transplantation of clone-derived stem cells in an animal model of aging. Cells generated by somatic cell nuclear transfer (SCNT) offer the...
Posted in Today's Stem Cell Research on June 29, 2005 10:35 AM
PhereSys Therapeutics Corp. Sheet
PhereSys Therapeutics Corp. Articles More PhereSys Therapeutics Corp. Articles Corporate Summary (site quote): PhereSys Therapeutics is a privately held company founded to become the premier therapeutic apheresis and cellular therapies provider in the United States. Therapeutic Apheresis or 'blood...
Posted in Today's Stem Cell Research on June 27, 2005 05:43 PM
10 'Daddies-to-Be' Kicked Off Father's Day Weekend at the Los Angeles Memorial Coliseum in the First-Ever Daddy Olympics as They Competed Against Each Other in Fatherly Skills
LOS ANGELES, June 17 -- The Olympic flame burned once again in Los Angeles this morning as 10 expectant fathers participated in the pursuit of "daddy gold medals," in the first-ever Daddy Olympics in front of The Los Angeles Memorial...
Posted in Today's Stem Cell Research on June 20, 2005 06:37 PM
Stem Cell Training Program To Make Its Stanford Debut
STANFORD, Calif. — For the first time ever, an advanced training program that teaches how to create and maintain embryonic stem cell lines will be offered outside of the University of Pittsburgh, where it originated in 2003. The weeklong course...
Posted in Today's Stem Cell Research on June 20, 2005 11:40 AM
Chemokine Therapeutics Announces Dual Trading on the TSX in Canada and the OTCBB in the U.S.
Vancouver, BC (June 15, 2005) – Chemokine Therapeutics Corp. (TSX: CTI, OTCBB: CHKT), a biotechnology company developing peptide-based therapies to treat cancer, blood disorders, cardiovascular, and infectious diseases, today announced that it has established trading in the United States in...
Posted in Today's Stem Cell Research on June 16, 2005 12:55 PM
Fertility Drugs and the Stem Cell Debate
The stem cell debate now brings us back to the years of fertility drugs, low-tech intra-uterine insemination and higher-tech in vitro fertilization (IVF). With that it brings us to the issue of a family after successfully having 2 children, now...
Posted in Today's Stem Cell Research on June 13, 2005 03:54 PM
Aastrom Biosciences' CEO to Present at The Morgan Stanley Small Cap Executive Conference
Ann Arbor, Michigan, June 10, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that R. Douglas Armstrong, Ph.D., Chief Executive Officer and Chairman, will present at the Morgan Stanley Small Cap Executive Conference. The conference will be held June...
Posted in Today's Stem Cell Research on June 12, 2005 11:51 AM
NIH Promoting Stem Cell Banks For Teeth
Medical officials from the U.S National Institute of Health (NIH) are encouraging private companies to start creating banks for stem cells that are obtained from baby and wisdom teeth. This paves the way for what could one day could be...
Posted in Today's Stem Cell Research on June 10, 2005 03:32 PM
StemCells, Inc. to Present at Morgan Stanley Small Cap Executive Conference
PALO ALTO, Calif.--(BUSINESS WIRE)--Jun 9, 2005 - StemCells, Inc. (NASDAQ: STEM) today announced that it will present at the Morgan Stanley Small Cap Executive Conference in New York, New York on Wednesday, June 15, 2005 at 8:00 am EDT. Following...
Posted in Today's Stem Cell Research on June 9, 2005 08:33 PM
Stem Cells Significantly Help Heart Failure Patients
More on the study coming out of Ecuador new study is out that shows that patients with advanced heart failure can show significant improvement after receiving stem cell therapy. This according to results of a small clinical trial presented as...
Posted in Today's Stem Cell Research on June 8, 2005 01:54 PM
Fetal Stem Cells Used To Fix Hearts
Wired is running an article about heart patients in Ecuador who have received fetal stem cell injections. The controversial scoop is that they are all showing signs of rapid recovery only three months after the treatment. Needless to say this...
Posted in Today's Stem Cell Research on June 7, 2005 01:33 PM
CuraGen Announces Single-Dose Phase I Data on Velafermin (CG53135) for Prevention of Oral Mucositis
NEW HAVEN, Conn., May 17 - CuraGen Corporation (Nasdaq: CRGN) today announced that Michael W. Schuster, M.D., Principal Investigator, Professor of Clinical Medicine in the Division of Hematology/Oncology at the Weill Medical College of Cornell University, and Director of Stem...
Posted in Today's Stem Cell Research on May 31, 2005 02:43 PM
Cord Blood America Provides Corporate Update Discussing Bill HR-2520 and Media Coverage For Cord Blood Stem Cell Transplants
LOS ANGELES, May 25, 2005 (PRIMEZONE) -- Cord Blood America, Inc. (OTCBB:CBAI), an umbilical cord blood stem cell preservation company, is pleased to provide this first installment in a series of Corporate Updates. The purpose of this information campaign is...
Posted in Today's Stem Cell Research on May 30, 2005 03:48 PM
Stem Cell Therapeutic and Research Act of 2005 (HR-2520) Passes the House of Representatives
RANCHO CORDOVA, Calif., May 25 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL) announced today that HR-2520, the "Stem Cell Therapeutic and Research Act of 2005" was passed by virtually unanimous decision by the House of Representatives. This Bill amends the Public...
Posted in Today's Stem Cell Research on May 30, 2005 11:27 AM
Geron Corporation To Present At UBS 2005 Global Pharmaceuticals Conference
Menlo Park, CA — May 20, 2005 -- Geron Corporation (Nasdaq: GERN) will be presenting an update of the company’s product development programs on Tuesday, May 24, 2005, at the UBS 2005 Global Pharmaceuticals Conference at 10:30 a.m., Eastern Time...
Posted in Today's Stem Cell Research on May 23, 2005 02:56 PM
Cord Blood Transplantation: An Update And View To The Future
A stem cell transplant from donated umbilical cord blood is sometimes the only hope a patient has for survival, but a patient's medical team may not be aware of the current stem cell options for patients in need of hematopoietic...
Posted in Today's Stem Cell Research on May 23, 2005 11:19 AM
Gene Keeps Neural Cells on Correct Developmental Path
Embryonic stem cells with identical genomes grow into distinctive tissues, such as heart, bone, and brain. At one time, scientists believed the differences among cell types arose from various sets of genes switched on inside developing cells. Then, studies showed...
Posted in Today's Stem Cell Research on May 20, 2005 02:13 PM
Sen. Sam Brownback Visits National Cord Blood Program, Meeting Cord Blood Recipients and Continuing His Support for A National Cord Blood Stem Cell Bank Network
NEW YORK, May 16 -- Sen. Sam Brownback (R-Kan.) toured New York Blood Center's National Cord Blood Program and met with cord blood transplant recipients Jaclyn Albanese and Stephen Sprague as a lead co-sponsor of the Cord Blood Stem Cell...
Posted in Today's Stem Cell Research on May 18, 2005 12:06 PM
PharmaFrontiers Adds Three Members to Its Scientific Advisory Board
THE WOODLANDS, Texas May 17, 2005 PharmaFrontiers Corp. (OTCBB:PFTR), a company involved in the development and commercialization of cell therapies, announced today that it has appointed three new members to its scientific advisory board (SAB). The new members are Norman...
Posted in Today's Stem Cell Research on May 17, 2005 01:54 PM
President's Council on Bioethics Report Outlines Human Embryonic Stem Cell Research Alternatives
As expected, the President's Council on Bioethics on Thursday released a report outlining possible ways to move forward with embryonic stem cell research without "upsetting ethical concerns" by describing methods for producing stem cells without destroying human embryos, Reuters...
Posted in Today's Stem Cell Research on May 16, 2005 01:48 AM
New York Senator Pushing for Umbilical Cord Blood Registry
New York Senator, Charles Schumer used Mother's Day to push for $15 million federal aid plan to be used to create a national registry for umbilical-cord donors. Schumer (D-N.Y.) is hoping that new mothers will be willing to donate umbilical...
Posted in Today's Stem Cell Research on May 9, 2005 11:14 AM
New York Concerned About Falling Behind in Stem Cell Research
Robert Palazzo, the head of Rensselaer Polytechnic Institute's (RPI) biotech effort is concerned that New York State is falling behind in stem-cell research. Not a shock considering the latest news regarding the final announcement of the California Institute of Regenerative...
Posted in Today's Stem Cell Research on May 9, 2005 11:00 AM
New York Times Covers California Stem Cell Headquarter Battle
This should come as no real news. However the NY Times has a good article on the frantic push to determine the location for the headquarters for California's new embryonic stem cell research program. So far, the overall goal is...
Posted in Today's Stem Cell Research on May 5, 2005 07:07 PM
BrainStorm Cell Therapeutics, Appoints Renowned Neurologists Prof. Warren Olanow and Prof. Andre Lozano to Scientific Advisory Board
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--April 27, 2005--BrainStorm Cell Therapeutics (OTCBB:BCLI), an emerging company in stem cell therapeutics for neurological diseases, today announced that Prof. Andre Lozano and Prof. C. Warren Olanow, internationally renowned clinical neurologists and researchers, have...
Posted in Today's Stem Cell Research on May 3, 2005 12:36 PM
Feminists For Life On Stem Cell Research
Feminists for Life of New York held a discussion about embryonic stem cell research this past Monday at Monroe Community College. The pro-life group's main speaker was the Rev. Tadeusz Pacholczyk, a Catholic priest who is the director at the...
Posted in Today's Stem Cell Research on April 25, 2005 06:30 PM
Human Neural Stem Cells Persist and Influence Nerve Cells in Rat Model of ALS
Roberta Friedman, PhD, Research Department Information Coordinator April 21, 2005 [QUICK SUMMARY: ALSA funded researchers placed genetically engineered human stem cells into rat spinal cord and showed that they can secrete, as instructed, a maintaining factor that aids the ability...
Posted in Today's Stem Cell Research on April 25, 2005 04:44 PM
Stem Cell Therapy International Sponsors Tech Council of Maryland's 'The Business of Stem Cell Research Conference'
NEW YORK--(BUSINESS WIRE)--April 21, 2005--Stem Cell Therapy International Corp. (SCTI), a leading supplier of xeno stem cells, that is, stem cells derived from animals, for transplant procedures in humans, announced that it is a sponsor and scholarship donor of "The...
Posted in Today's Stem Cell Research on April 22, 2005 09:14 AM
John G. Coles, MD Joins Multicell's Scientific Advisory Board Stem Cell Panel
SAN DIEGO--(BUSINESS WIRE)--April 20, 2005--MultiCell Technologies, Inc. (OTCBB: MUCL), a leading supplier of immortalized non-tumorigenic human hepatocytes as pharmaceutical candidate optimization tools, announced today that it has appointed Dr. John Coles to MultiCell's new stem cell panel of the Scientific...
Posted in Today's Stem Cell Research on April 20, 2005 08:23 PM
Dr. Stephen Chang, President of MultiCell Technologies Inc., Talks to The Wall Street Transcript
NEW YORK--(BUSINESS WIRE)--April 19, 2005--The Wall Street Transcript has published an in-depth interview with Dr. Stephen Chang, President of MultiCell Technologies Inc. (OTCBB:MUCL) in which he talks at length about the Company....
Posted in Today's Stem Cell Research on April 19, 2005 07:14 PM
Report Proposes Structure for National Network of Cord Blood Stem Cell Banks
WASHINGTON -- To achieve a more cohesive national system for storing and distributing lifesaving stem cells derived from umbilical cord blood, the U.S. Department of Health and Human Services should establish a new National Cord Blood Policy Board to set...
Posted in Today's Stem Cell Research on April 15, 2005 02:53 PM
Stem Cell Services Re-Named to Better Reflect Its Corporate Culture of Creating and Sustaining Families; Family Cord Blood Services to Serve as New Moniker for a Recognized Leader in Cord Blood Banking
LOS ANGELES--(BUSINESS WIRE)--Apr 12, 2005 - California Cryobank Stem Cell Services, an umbilical cord blood processing and storage company, and division of one of the largest and oldest reproductive tissue banks in the world, California Cryobank, Inc., announced today that...
Posted in Today's Stem Cell Research on April 12, 2005 10:01 PM
New Cord Blood Bank To Be Opened in Scotland
A new cord blood bank targeting the storage of stem cell-rich umbilical cord blood is to be established in the west of Scotland. Glasgow is the likely location. This new facility will allow mothers to voluntarily donate blood left in...
Posted in Today's Stem Cell Research on April 11, 2005 01:23 PM
N.Y. Blood Center Scientists and Cord Blood Transplant Recipients Cured of Leukemia and Sickle Cell Disease Call for Passage of Cord Blood Stem Cell Act; Photo Available
WASHINGTON, April 4 /U.S. Newswire/ -- Marking another milestone in New York Blood Center's (NYBC) continuing mission to save lives, NYBC President/CEO, Robert L. Jones, M.D. and National Cord Blood Program Director, Pablo Rubinstein, M.D., were joined today by Sen....
Posted in Today's Stem Cell Research on April 5, 2005 12:12 AM
Scientists, Cord Blood Transplant Recipients Call on Senate to Pass S681 Establishing National Cord Blood Stem Cell Bank Network; Bill Would Create More Options for Critically Ill Patients
WASHINGTON, April 1 /U.S. Newswire/ -- New York Blood Center's (NYBC) President and CEO, Robert L. Jones, M.D., its National Cord Blood Program Director, Pablo Rubinstein, M.D., cord blood transplant recipients, will join Senator Orrin G. Hatch (R-Utah) -- a...
Posted in Today's Stem Cell Research on April 2, 2005 12:07 AM
Chemokine Therapeutics Corp. Sheet
Chemokine Therapeutics (TSX: CTI, OTCBB: CHKT) Corp. Sheet Chemokine Therapeutics Corp. Articles More Chemokine Therapeutics Corp. Articles Corporate Summary (site quote): Chemokine Therapeutics is a publicly-held biotechnology company with emphasis on peptide therapeutics. The Company discovers, develops, and manufactures innovative...
Posted in Today's Stem Cell Research on April 1, 2005 06:31 PM
Taking Stem Cell Research from Mouse to Man - University of Toronto Bioengineer Captures Prestigious Canadian Research Prize
OTTAWA, March 31 /CNW Telbec/ - Since the headline-making discovery of the first human embryonic stem cells in 1998, there's been ongoing public buzz about the potential curative powers of these primitive cells. "At the end of the day, if...
Posted in Today's Stem Cell Research on April 1, 2005 09:40 AM
Cord Blood Transplant Recipients Call on Senate to Pass Cord Blood Stem Cell Act of 2005; Photo Available
To: Assignment Desk, Daybook Editor, Photo Editor Contact: Rich Miller-Murphy of the New York Blood Center, 212-570-3101 or 917-439-1727, Gladwyn Lopez of Rubenstein Communications, Inc., 212-843-9231 or 917-763-5336 News Advisory: -- First Patient Cured of Sickle Cell Disease and Adult...
Posted in Today's Stem Cell Research on March 31, 2005 11:46 PM
BrainStorm Appoints Prof. Jeffrey Kordower to its Scientific Advisory Board; World Renowned Neurologist and Specialist in Gene and Neural Transplantation to Provide Company Invaluable Guidance
TEL AVIV, Israel - BrainStorm Cell Therapeutics (OTCBB:BCLI), an emerging company in stem cell therapeutics for neurological diseases, today announced that Prof. Jeffrey Kordower, globally renowned neurologist scientist has joined the Company's Scientific Advisory Board, bringing a wealth of experience...
Posted in Today's Stem Cell Research on March 31, 2005 05:53 PM
Cord Blood Transplant in New Jersey Stops Krabbe Disease Progression
Ashleigh Gwin was diagnosed at 7 months old with Krabbe (krahb-AY) disease. Krabbe Disease is a genetic disorder that is usually fatal by the age of 2 unless treated successfully. Ashleigh, who is now 28 months old, has since undergone...
Posted in Today's Stem Cell Research on March 28, 2005 07:11 PM
Stem Cell Opponents Target Sen. Saland In New York
In a March 4 mailing from the New York State Right to Life Committee, Inc. instructs recipients to call state Senator Steve Saland (R-41st) immediately and demand he withdraw his support for what the letter calls a "clone & kill"...
Posted in Today's Stem Cell Research on March 28, 2005 02:22 PM
More Push for Stem Cell Research Funding in New York
Scientists from New York area universities and biotech companies joined with local activist Brooke Ellison and Rep. Steven Israel (D-Huntington) yesterday to demand that New York approve funding for medical research using embryonic stem cells. Througough this month, legislation has...
Posted in Today's Stem Cell Research on March 25, 2005 05:54 PM
Legislation to Create a National Inventory of 150,000 Cord Blood Stem Cell Units Introduced in the Senate (S-681) and House (H.R. 596)
RANCHO CORDOVA, Calif., March 21 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL) announced today that S-681 titled "Cord Blood Stem Cell Act of 2005" was introduced on March 17, 2005 in the Senate "to establish a National Cord Blood Stem Cell...
Posted in Today's Stem Cell Research on March 22, 2005 04:51 PM
SCTI Retains Stern & Co. to Provide Integrated Investor and Media Relations Campaign
NEW YORK-March 21, 2005-Stem Cell Therapy International Corp. (SCTI), a leading supplier of xeno stem cells, that is, stem cells derived from animals, for transplant procedures in humans, today announced it has retained New York-based Stern & Co. to initiate...
Posted in Today's Stem Cell Research on March 21, 2005 05:18 PM
Stem Cell Research and the Avalanche of State-Funded Initiatives
New York, March 16 - The New York Biotechnology Association (NYBA) announced today that its 2005 Annual meeting keynote luncheon program would focus on the impact major state funded initiatives such as Proposition 71 in California could have on biotech...
Posted in Today's Stem Cell Research on March 17, 2005 01:09 PM
Bio-Matrix Scientific Group Appoints Dr. Geoffrey O'Neill -- Formerly of Cryo-Cell International as New Bio-Matrix President
SAN DIEGO--(BUSINESS WIRE)--March 10, 2005--Bio-Matrix Scientific Group Inc. today announced that it appointed Geoffrey O'Neill, Ph.D. as President of the Company. Dr. O'Neill most recently served as Director of Stem Cell Laboratories and Scientific Research for Cryo-Cell International Inc. (OTCBB:...
Posted in Today's Stem Cell Research on March 10, 2005 06:31 PM
Stem-Cell Firms Rise On Funding News
Shares of StemCells Inc. (STEM) spiked 15 percent to close at $4.98, while Aastrom BioSciences (ASTM) rose 18 percent to $3.09. Shares of Geron (GERN) also advanced, up 7 percent to $7.41. Reports circulated on Wednesday that New York State...
Posted in Today's Stem Cell Research on March 3, 2005 02:43 AM
Cord Blood America Announces Launch of Professional Services Practice
Cord Blood America, parent company of Cord Partners, a family cord blood preservation company, announced today that it has launched Cord Blood America Professional Services (CBA Professional Services), a wholly owned subsidiary of Cord Blood America. The CBA Professional Services...
Posted in Today's Stem Cell Research on March 2, 2005 01:19 PM
Stem Cell Research Focus of Spending in New York
New York State lawmakers from both parties yesterday proposed spending at least $100 million a year on stem cell research. New York is not alone ... a growing number of states are moving to fund regional efforts partly as a...
Posted in Today's Stem Cell Research on March 2, 2005 01:12 PM
US Patent Office Rejects PharmaStem Cord Blood Stem Cell Patents
ThermoGenesis Corp. (Nasdaq: KOOL), a supplier of cryogenic devices used by cord blood banks, and NETCORD, the leading international network of public cord blood banks, today announced that the U.S. Patent Office (PTO) has reexamined U.S. Patent 5,192,553 (Patent '553)...
Posted in Today's Stem Cell Research on March 1, 2005 07:47 PM
Cord Blood America Announces Acquisition of RainMakers International
Cord Blood America, Inc. (OTC BB: CBAI), parent company of Cord Partners, a family cord blood preservation company, announced today that it has acquired RainMakers International, Inc., of Los Angeles, CA. RainMakers International provides direct response advertising for family-based products...
Posted in Today's Stem Cell Research on March 1, 2005 02:48 AM
ThromboGenics Ltd. Corp. Sheet
ThromboGenics Ltd. Corp. Articles More ThromboGenics Ltd. Corp. Articles Corporate Summary (site quote): ThromboGenics Ltd is a privately held company founded in Dublin, Ireland in 1998, focused on discovery and development of biotherapeutics for treatment of vascular diseases (including...
Posted in Today's Stem Cell Research on February 28, 2005 03:02 PM
Fernandes Approved for Stem Cell Surgery in Portugal
Mr. Cisco Fernandes injured his spine in a diving accident in New York state June 17, 2000, and became a quadriplegic, being paralyzed from the chest down. He is hopeful that by undergoing an experimental surgery he will regain at...
Posted in Today's Stem Cell Research on February 26, 2005 06:57 PM
Stem Cell Injection Into Patients With Congestive Heart Failure Show Marked Improvement
University of Pittsburgh researchers are now reporting the results of a randomized trial which is a new approach at Society for Thoracic Surgery meeting. Patients with severe congestive heart failure showed significantly improved heart function following a procedure in which...
Posted in Today's Stem Cell Research on February 25, 2005 07:04 PM
Hadassah Pushing Stem-cell Legislation
In a move that is likely to bring it into conflict with Catholic and Evangelical Christian groups, the largest Jewish organization in America is launching a push for pro-stem-cell-research legislation in state houses around the country. Hadassah, the 300,000-member women's...
Posted in Today's Stem Cell Research on February 24, 2005 12:59 PM
Massachusetts: Boston City Councilor Promotes Cord Blood Banking
A Boston city councilor is considering a measure to promote the controversial practice of storing the blood from umbilical cords as a source of stem cells for future medical treatments for the child, parent, or sibling. Councilor John Tobin stated...
Posted in Today's Stem Cell Research on February 24, 2005 12:46 PM
Cord Blood Bank List
With stem cell research so closely tied to Umbilical Cord Blood, we thought it a good idea to get a somewhat comprehensive list of Cord Blood Banks put together. Additionally, since we have been tracking a many stem cell research...
Posted in Today's Stem Cell Research on February 22, 2005 01:55 PM
Connecticut : Mayor says Rell budget will hurt city's programs
More from Connecticut, Mayor John DeStefano Jr. has loudly voiced his opinion that Connecticut Gov. M. Jodi Rell's state budget proposal would have a negative economic impact on New Haven, and some of the city's business leaders agree. Rell's proposal...
Posted in Today's Stem Cell Research on February 18, 2005 01:02 PM
Washington: More on the Latest U.S. Bills Seek to Promote Stem Cell Research
Attempting to circumvent President Bush's limits on the use of stem cells from human embryos, members of Congress on Wednesday introduced bills to allow federal funding of embryonic stem cell research. Supporters from BOTH major parties joined the coordinated introduction...
Posted in Today's Stem Cell Research on February 17, 2005 12:05 AM
Call On US House Legislators to Pass the Cord Blood Stem Cell Act of 2005 (H.R. 596)
Rep. Chris Smith (R- N.J.), a leader of health initiatives in Congress, was joined by New York Blood Center's (NYBC) President/CEO, Robert L. Jones, M.D., its National Cord Blood Program Director, Pablo Rubinstein, M.D., and cord blood transplant recipients, at...
Posted in Today's Stem Cell Research on February 15, 2005 12:37 AM
Legislators Say Romney's Position on Stem Cells Hurts State
Lawmakers and scientists say Gov. Mitt Romney's announced opposition to human embryonic stem cell research represents a sudden change in position that threatens vital research in Massachusetts. "He's clouding the issue," said Rep. Peter Koutoujian, D-Waltham, who supports legislation allowing...
Posted in Today's Stem Cell Research on February 14, 2005 05:35 PM
MacroPore Biosurgery to Present at the BIO CEO & Investor Conference
MacroPore Biosurgery, Inc. (Frankfurt: XMP) announced today that it will host an audio webcast of its corporate presentation at the BIO CEO & Investor Conference in New York, NY on Thursday, February 24, 2005 at 3:30 p.m. Eastern Standard Time....
Posted in Today's Stem Cell Research on February 13, 2005 09:33 PM
California: What Is The Worst Thing One Can Do To Politicians? Give Them Money
Well, not that it would come as any real suprise, but now with Prop 71 basically a thing of the past, here comes the drama. Now that the politicians have gotten the state to approve effectively $3 Billion in funding...
Posted in Today's Stem Cell Research on February 13, 2005 02:54 PM
Massachusetts: Gov. W. Mitt Romney Reverses Stance on Stem Cell Research
Just as the State Legislature was about to begin debating a plan to encourage stem cell research in Massachusetts, Gov. W. Mitt Romney has seemingly reversed his previous stance. Romney, who had previously expressed support for the research, now says...
Posted in Today's Stem Cell Research on February 13, 2005 12:59 AM
Massachusetts Democrats Object to Stem Cell Research Ban
Massachusetts Democrats and several prominent researchers unleashed a flurry of objections on Thursday to Gov. Mitt Romney's proposal to outlaw a form of embryonic stem cell research. After a report on Thursday in The New York Times that Mr. Romney,...
Posted in Today's Stem Cell Research on February 11, 2005 01:35 PM
Massachusetts: Cord Blood Banking Only Makes Sense if It's a Shared Effort
How much would you pay to guard your newborn against the future risk of fatal cancer, heart disease, immune problems, and many other serious diseases? Companies such as Cord Blood Registry, Boston-based Viacord, and about 20 others are betting that...
Posted in Today's Stem Cell Research on February 10, 2005 12:09 PM
Cord Blood America Inc. Announces Strategic Alliance
Cord Blood America Inc. announced today that it has established a strategic alliance with Premier Funding and Financial Marketing Services of Phoenix, Arizona. Premier Funding will focus on Corporate Imaging and Retail Market awareness for the existing and new shareholder...
Posted in Today's Stem Cell Research on February 10, 2005 11:28 AM
US Congressional Representatives Promote Cord Blood Banking
Rep. Chris Smith (N.J.), a leader of health initiatives in Congress, will be joined by New York Blood Center's (NYBC) President/CEO, Robert L. Jones, M.D., its National Cord Blood Program Director, Pablo Rubinstein, M.D., and cord blood transplant recipients, at...
Posted in Today's Stem Cell Research on February 8, 2005 12:44 AM
UBDF 3:1 Forward Split Effective Monday
Stem Cell stocks rebounded Friday as a recent Los Angeles Times article quoted UC San Francisco professor, Susan Fisher, explaining the importance of Prop. 71, which provides $3 billion in funding for stem cell research, circumventing President Bush's Federal restrictions....
Posted in Today's Stem Cell Research on February 1, 2005 09:16 PM
Stem Cell Funding Sparks Rush and Brain Drain
The inboxes of prominent California medical and biological researchers are beginning to collect inquiries from out-of-state undergrads, post-docs and well-placed scientists interested in stem cell research. The subject is simple and direct: Is California the place I ought to go?...
Posted in Today's Stem Cell Research on February 1, 2005 11:52 AM
ThermoGenesis Corp. (KOOL) Corp. Sheet
ThermoGenesis Corp. Articles More ThermoGenesis Corp. Articles Corporate Summary (site quote): ThermoGenesis Corp. is a leader in enabling technologies for cell therapeutics. The Company's technology platforms lead the world in their ability to produce biological products from single units...
Posted in Today's Stem Cell Research on January 21, 2005 03:54 PM
More on U.S. State Level Stem Cell Funding
Current State level developments in the funding of stem cell research is still moving forward at a rapid pace: New York state Sen. David Paterson, a Democrat, introduced legislation last weekend that, if approved by voters, would dedicate $1 billion...
Posted in Today's Stem Cell Research on January 20, 2005 11:56 AM
Stem Cell Research Companies List
Aastrom Biosciences LifeCell Corporation Advanced Cell Technologies Inc. MacroPore Biosurgery AnorMED Inc. Mesoblast Limited AVI BioPharma MultiCell Technologies, Inc. BioE, Inc. Osiris Therapeutics Bio-Matrix Scientific Group Inc. PharmaFrontiers Corp. BrainStorm Cell Therapeutics Inc. PhereSys Therapeutics Cartilix Pluristem Life...
Posted in Today's Stem Cell Research on January 5, 2005 03:59 PM
Asia Is Becoming Stem Cell Central
Alan Colman - English biochemist and a leader of the British team that created the first cloned mammal in 1997, says that Singapore is creating "a center of excellence in stem cell research" and that there is plenty of funding...
Posted in Today's Stem Cell Research on January 3, 2005 12:04 PM
NY Spano pushes Gov. Pataki for Stem Cell Bond
Westchester County Executive Andrew Spano wants New York to follow California's example and hold a statewide referendum to fund stem cell research.... Finally, some East Coast support! Read On...
Posted in Today's Stem Cell Research on December 21, 2004 10:57 AM
More on Stem Cell Heart Research and Angioblasts .. plus a good illustration
Silviu Itescu, MD, Director of Transplantation Immunology for the Departments of Surgery and Medicine at New York-Presbyterian Hospital/Columbia University Medical Center has been showing that if adult blood vessel stem cells, known as angioblasts, are injected into animals with damaged...
Posted in Today's Stem Cell Research on December 15, 2004 12:05 PM
Cells Generate New Cardiac Tissue
Researchers in New York found a reservoir of stem cells in the heart - cells programmed to generate new cardiac tissue. The discovery crumbled a centuries-old medical dogma: that we are born with all the heart cells we'll ever have...
Posted in Today's Stem Cell Research on December 13, 2004 11:33 AM
More Evidence that Leukemia Treatments With Stem Cell Transplants Have Higher Survival
Another study published in the New England Journal of Medicine again confirms that stem cells derived from the umbilical cords of newborn babies are a viable and highly effective stem cell source for thousands of leukemia patients who have limited...
Posted in Today's Stem Cell Research on November 30, 2004 10:35 AM